ClinicalTrials.gov 临床试验·· 16 天前AI 评分22
navlimetostat(BMS-986504)联合 mFOLFIRINOX 围手术治疗 MTAP 缺失胰腺癌研究
A Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer
AI 导读
一项临床试验评估 navlimetostat(BMS-986504)联合 mFOLFIRINOX 在 MTAP 缺失的局限性胰腺癌患者术前术后的安全性、可行性和推荐剂量。
来源:ClinicalTrials.gov 临床试验 · clinicaltrials.gov